tetano
Editor, Senior Moderator
Eur J Pharmacol
. 2020 Jun 16;173288.
doi: 10.1016/j.ejphar.2020.173288. Online ahead of print.
Endoplasmic Reticulum as a Potential Therapeutic Target for covid-19 Infection Management?
Antoni Sureda[SUP] 1 [/SUP], Javad Alizadeh[SUP] 2 [/SUP], Seyed Fazel Nabavi[SUP] 3 [/SUP], Ioana Berindan Neagoe[SUP] 4 [/SUP], Cosmin Andrei Cismaru[SUP] 5 [/SUP], Philippe Jeandet[SUP] 6 [/SUP], Marek J Los[SUP] 7 [/SUP], Emilio Clementi[SUP] 8 [/SUP], Seyed Mohammad Nabavi[SUP] 9 [/SUP], Saeid Ghavami[SUP] 10 [/SUP]
Affiliations
Abstract
In December 2019, many pneumonia cases with unidentified sources appeared in Wuhan, Hubei, China, with clinical symptoms like viral pneumonia. Deep sequencing analysis of samples from lower respiratory tract revealed a novel coronavirus, called 2019 novel coronavirus (2019-nCoV). Currently there is a rapid global spread. World Health Organization declare the disease a pandemic condition. The pathologic source of this disease was a new RNA virus from Coronaviridae family, which was named COVID-19. SARS-CoV-2 entry starts with the binding of the spike glycoprotein expressed on the viral envelope to ACE2 on the alveolar surface followed by clathrin-dependent endocytosis of the SARS-CoV-2 and ACE2 complex. SARS-CoV-2 enters the cells through endocytosis process, which is possibly facilitated, via a pH dependent endosomal cysteine protease cathepsins. Once inside the cells, SARS-CoV-2 exploits the endogenous transcriptional machinery of alveolar cells to replicate and spread through the entire lung. Endosomal acidic pH for SARS-CoV-2 processing and internalization is critical. After entering the cells, it possibly activates or hijack many intracellular pathways in favor of its replication. In the current opinion article, we will explain the possible involvement of unfolded protein response as a cellular stress response to the SARS-CoV-2 infection.
Keywords: Endoplasmic reticulum; IRE1; PERK; Spliced XBP1; Unfolded protein response.
. 2020 Jun 16;173288.
doi: 10.1016/j.ejphar.2020.173288. Online ahead of print.
Endoplasmic Reticulum as a Potential Therapeutic Target for covid-19 Infection Management?
Antoni Sureda[SUP] 1 [/SUP], Javad Alizadeh[SUP] 2 [/SUP], Seyed Fazel Nabavi[SUP] 3 [/SUP], Ioana Berindan Neagoe[SUP] 4 [/SUP], Cosmin Andrei Cismaru[SUP] 5 [/SUP], Philippe Jeandet[SUP] 6 [/SUP], Marek J Los[SUP] 7 [/SUP], Emilio Clementi[SUP] 8 [/SUP], Seyed Mohammad Nabavi[SUP] 9 [/SUP], Saeid Ghavami[SUP] 10 [/SUP]
Affiliations
- PMID: 32561291
- DOI: 10.1016/j.ejphar.2020.173288
Abstract
In December 2019, many pneumonia cases with unidentified sources appeared in Wuhan, Hubei, China, with clinical symptoms like viral pneumonia. Deep sequencing analysis of samples from lower respiratory tract revealed a novel coronavirus, called 2019 novel coronavirus (2019-nCoV). Currently there is a rapid global spread. World Health Organization declare the disease a pandemic condition. The pathologic source of this disease was a new RNA virus from Coronaviridae family, which was named COVID-19. SARS-CoV-2 entry starts with the binding of the spike glycoprotein expressed on the viral envelope to ACE2 on the alveolar surface followed by clathrin-dependent endocytosis of the SARS-CoV-2 and ACE2 complex. SARS-CoV-2 enters the cells through endocytosis process, which is possibly facilitated, via a pH dependent endosomal cysteine protease cathepsins. Once inside the cells, SARS-CoV-2 exploits the endogenous transcriptional machinery of alveolar cells to replicate and spread through the entire lung. Endosomal acidic pH for SARS-CoV-2 processing and internalization is critical. After entering the cells, it possibly activates or hijack many intracellular pathways in favor of its replication. In the current opinion article, we will explain the possible involvement of unfolded protein response as a cellular stress response to the SARS-CoV-2 infection.
Keywords: Endoplasmic reticulum; IRE1; PERK; Spliced XBP1; Unfolded protein response.